GYRE

SEC source: 0001140361-26-022235 · form4.xml · nonDerivative · entry 2

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.6102 to $6.6215. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-26-022235 · form4.xml · nonDerivative · entry 1

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-26-021889 · form4.xml · derivative · entry 6

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 936,435

Underlying: Common Stock · 13,100 shares

Expires 2030-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are vested in full.

SEC source: 0001140361-26-021889 · form4.xml · nonDerivative · entry 4

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.58 to $6.85. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-26-021889 · form4.xml · nonDerivative · entry 3

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 713,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-26-021889 · form4.xml · derivative · entry 5

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 949,535

Underlying: Common Stock · 15,580 shares

Expires 2030-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are vested in full.

SEC source: 0001140361-26-021889 · form4.xml · nonDerivative · entry 2

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.8326 to $7.28. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-26-021889 · form4.xml · nonDerivative · entry 1

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 715,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-26-022303 · form4.xml · derivative · entry 1

Zhang Ping · CIK 0002050176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 250,000 shares

Expires 2035-05-27

F1 · kind: The option was canceled by mutual agreement of the Reporting Person and the Issuer. The Issuer shall provide the Reporting Person with consideration for the cancellation of the option, the form and amount of which shall be determined by the Issuer in its sole discretion; provided that such consideration shall not be economic in value.

F1 · price: The option was canceled by mutual agreement of the Reporting Person and the Issuer. The Issuer shall provide the Reporting Person with consideration for the cancellation of the option, the form and amount of which shall be determined by the Issuer in its sole discretion; provided that such consideration shall not be economic in value.

F2 · derivative.exercise_date: The canceled option represented a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which would have vested on May 27, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-019658 · form4.xml · nonDerivative · entry 2

Luo Ying · CIK 0001959160 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,565,226

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.071. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-26-019658 · form4.xml · nonDerivative · entry 1

Luo Ying · CIK 0001959160 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,575,362

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.

SEC source: 0001140361-26-019378 · form4.xml · derivative · entry 2

GNI Group Ltd. · CIK 0001958461 · 10% owner

GNI USA, Inc. · CIK 0001973229 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 2,143,706

Underlying: Common Stock · 10,718,530 shares

Expires not disclosed

F1 · derivative.exercise_price: Following Stockholder Approval, each share of Series B Preferred Stock will be convertible, at the option of the holder, into five shares of common stock, subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for Series B Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on March 2, 2026).

F2 · shares: Effective as of May 4, 2026 (the "Effective Time"), a wholly-owned subsidiary of the Issuer merged with and into Cullgen Inc. ("Cullgen") with Cullgen surviving as a wholly-owned subsidiary of the Issuer (the "Merger").

F3 · shares: Represents the number of shares of Series B Preferred Stock of the Issuer received by the Reporting Person in the Merger in exchange for the shares of capital stock of Cullgen held by the Reporting Person prior to the Merger. Each share of capital stock of Cullgen held at the Effective Time was exchanged for 0.4753 divided by five shares of Series B Preferred Stock.

F1 · price: Following Stockholder Approval, each share of Series B Preferred Stock will be convertible, at the option of the holder, into five shares of common stock, subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for Series B Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on March 2, 2026).

F1 · derivative.exercise_date: Following Stockholder Approval, each share of Series B Preferred Stock will be convertible, at the option of the holder, into five shares of common stock, subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for Series B Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on March 2, 2026).

F4 · derivative.expiration_date: The Series B Preferred Stock has no expiration date.

F2 · balance_after: Effective as of May 4, 2026 (the "Effective Time"), a wholly-owned subsidiary of the Issuer merged with and into Cullgen Inc. ("Cullgen") with Cullgen surviving as a wholly-owned subsidiary of the Issuer (the "Merger").

F3 · balance_after: Represents the number of shares of Series B Preferred Stock of the Issuer received by the Reporting Person in the Merger in exchange for the shares of capital stock of Cullgen held by the Reporting Person prior to the Merger. Each share of capital stock of Cullgen held at the Effective Time was exchanged for 0.4753 divided by five shares of Series B Preferred Stock.

F6 · ownership.nature: These securities are held by GNI USA. GNI Japan may be deemed for purposes of Section 16 of the Exchange Act to be the indirect beneficial owner of the securities held by GNI USA.

SEC source: 0001140361-26-019378 · form4.xml · derivative · entry 1

GNI Group Ltd. · CIK 0001958461 · 10% owner

GNI USA, Inc. · CIK 0001973229 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 458,120

Underlying: Common Stock · 2,290,600 shares

Expires not disclosed

F1 · derivative.exercise_price: Following Stockholder Approval, each share of Series B Preferred Stock will be convertible, at the option of the holder, into five shares of common stock, subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for Series B Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on March 2, 2026).

F2 · shares: Effective as of May 4, 2026 (the "Effective Time"), a wholly-owned subsidiary of the Issuer merged with and into Cullgen Inc. ("Cullgen") with Cullgen surviving as a wholly-owned subsidiary of the Issuer (the "Merger").

F3 · shares: Represents the number of shares of Series B Preferred Stock of the Issuer received by the Reporting Person in the Merger in exchange for the shares of capital stock of Cullgen held by the Reporting Person prior to the Merger. Each share of capital stock of Cullgen held at the Effective Time was exchanged for 0.4753 divided by five shares of Series B Preferred Stock.

F1 · price: Following Stockholder Approval, each share of Series B Preferred Stock will be convertible, at the option of the holder, into five shares of common stock, subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for Series B Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on March 2, 2026).

F1 · derivative.exercise_date: Following Stockholder Approval, each share of Series B Preferred Stock will be convertible, at the option of the holder, into five shares of common stock, subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for Series B Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on March 2, 2026).

F4 · derivative.expiration_date: The Series B Preferred Stock has no expiration date.

F2 · balance_after: Effective as of May 4, 2026 (the "Effective Time"), a wholly-owned subsidiary of the Issuer merged with and into Cullgen Inc. ("Cullgen") with Cullgen surviving as a wholly-owned subsidiary of the Issuer (the "Merger").

F3 · balance_after: Represents the number of shares of Series B Preferred Stock of the Issuer received by the Reporting Person in the Merger in exchange for the shares of capital stock of Cullgen held by the Reporting Person prior to the Merger. Each share of capital stock of Cullgen held at the Effective Time was exchanged for 0.4753 divided by five shares of Series B Preferred Stock.

F5 · ownership.nature: These securities are held by GNI Group Ltd., a company incorporated under the laws of Japan with limited liability ("GNI Japan"). GNI USA, Inc., a Delaware corporation ("GNI USA") is a wholly-owned subsidiary of GNI Japan. GNI USA may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to be the indirect beneficial owner of the securities held by GNI Japan.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 7

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 33,271

Underlying: Common Stock · 33,271 shares

Expires 2028-06-07

F1 · derivative.exercise_date: This option is fully vested.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 6

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,683

Underlying: Common Stock · 92,683 shares

Expires 2034-11-12

F2 · derivative.exercise_date: This option represents a right to purchase 92,683 shares of the Issuer's common stock, one quarter of which vested on November 13, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 5

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,060

Underlying: Common Stock · 95,060 shares

Expires 2032-01-23

F1 · derivative.exercise_date: This option is fully vested.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 4

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,271

Underlying: Common Stock · 33,271 shares

Expires 2031-06-09

F1 · derivative.exercise_date: This option is fully vested.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 3

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,882

Underlying: Common Stock · 11,882 shares

Expires 2030-12-17

F1 · derivative.exercise_date: This option is fully vested.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 2

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,530

Underlying: Common Stock · 47,530 shares

Expires 2030-01-12

F1 · derivative.exercise_date: This option is fully vested.

SEC source: 0001140361-26-019376 · form4.xml · derivative · entry 1

Eastling Thomas Wilson · CIK 0001958487 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,060

Underlying: Common Stock · 95,060 shares

Expires 2028-06-07

F1 · derivative.exercise_date: This option is fully vested.

SEC source: 0001140361-26-000832 · form4.xml · derivative · entry 1

Zhang Ping · CIK 0002050176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-01-07

F1 · derivative.exercise_date: This option represents a right to purchase a total of 100,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-000831 · form4.xml · derivative · entry 1

Chen Ruoyu · CIK 0001982080 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-01-07

F1 · derivative.exercise_date: This option represents a right to purchase a total of 50,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-032719 · form4.xml · derivative · entry 1

Weng Dan · CIK 0002083482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,000

Underlying: Common Stock · 52,000 shares

Expires 2035-08-18

F1 · derivative.exercise_date: This option represents a right to purchase a total of 52,000 shares of the Issuer's common stock, which will vest in 36 equal monthly installments through August 18, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-029693 · form4.xml · derivative · entry 1

Zhang Ping · CIK 0002050176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-08-05

F1 · derivative.exercise_date: This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on August 5, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-021793 · form4.xml · derivative · entry 1

Eastling Thomas Wilson · CIK 0001958487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-021792 · form4.xml · derivative · entry 1

Epstein David M. · CIK 0001488668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-021791 · form4.xml · derivative · entry 1

Nussbaum Rodney L · CIK 0002014225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-021790 · form4.xml · derivative · entry 1

Parry Renate · CIK 0001982817 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-021789 · form4.xml · derivative · entry 1

Carmichael Gordon · CIK 0001982077 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-020754 · form4.xml · nonDerivative · entry 2

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,806,084

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.29. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-020669 · form4.xml · derivative · entry 1

Zhang Ping · CIK 0002050176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-05-27

F1 · derivative.exercise_date: This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on May 27, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-020754 · form4.xml · nonDerivative · entry 1

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,806,642

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.00 to $11.44. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-020474 · form4.xml · nonDerivative · entry 2

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,808,642

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.58. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-020474 · form4.xml · nonDerivative · entry 1

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,808,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.215 to $11.27. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-020156 · form4.xml · nonDerivative · entry 2

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,810,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.32 to $11.275. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-020156 · form4.xml · nonDerivative · entry 1

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,812,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.925 to $11.42. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-019893 · form4.xml · nonDerivative · entry 2

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,814,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.02 to $11.215. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-019893 · form4.xml · nonDerivative · entry 1

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,816,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.82 to $11.58. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-019468 · form4.xml · nonDerivative · entry 2

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,818,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.435 to $10.93. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-019468 · form4.xml · nonDerivative · entry 1

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,820,824

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at price of $11.30. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-018927 · form4.xml · nonDerivative · entry 2

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,820,844

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.16 to $11.69. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-018927 · form4.xml · nonDerivative · entry 1

Ma Songjiang · CIK 0001985547 · Director · President

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 2,822,844

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.885. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-25-014601 · form4.xml · derivative · entry 2

Eastling Thomas Wilson · CIK 0001958487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,652

Underlying: Common Stock · 15,000 shares

Expires 2033-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options are vested in full.

SEC source: 0001140361-25-014601 · form4.xml · nonDerivative · entry 1

Eastling Thomas Wilson · CIK 0001958487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-019053 · form4.xml · derivative · entry 2

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 965,115

Underlying: Common Stock · 50,000 shares

Expires 2030-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options are vested in full.

SEC source: 0001140361-25-019053 · form4.xml · nonDerivative · entry 1

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-015712 · form4.xml · derivative · entry 6

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,015,115

Underlying: Common Stock · 150,000 shares

Expires 2030-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options are vested in full.

SEC source: 0001140361-25-015712 · form4.xml · nonDerivative · entry 3

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-015712 · form4.xml · derivative · entry 5

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,165,115

Underlying: Common Stock · 200,000 shares

Expires 2030-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options are vested in full.

SEC source: 0001140361-25-015712 · form4.xml · nonDerivative · entry 2

Ye Weiguo · CIK 0001985496 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.